Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / COMMON STOCK, PAR V ALUE $0.001 PER SHARE
-
Shares outstanding
-
79,310,345
-
Number of holders
-
100
-
Total 13F shares, excl. options
-
19,135,638
-
Shares change
-
+1,889,358
-
Total reported value, excl. options
-
$154,655,147
-
Value change
-
+$21,831,393
-
Put/Call ratio
-
330%
-
Number of buys
-
54
-
Number of sells
-
36
-
Price
-
$8.08
Institutional Holders of CorMedix Inc. - COMMON STOCK, PAR V ALUE $0.001 PER SHARE (CRMD) as of Q3 2024
As of 30 Sep 2024 CorMedix Inc. - COMMON STOCK, PAR V ALUE $0.001 PER SHARE (CRMD) had 123 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 19,135,638 shares of stock of the company.
Largest 10 holders included BlackRock, Inc., VANGUARD GROUP INC, Elliott Investment Management L.P., Rosalind Advisors, Inc., GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, Voya Investment Management LLC, NORTHERN TRUST CORP, KENNEDY CAPITAL MANAGEMENT LLC, and MORGAN STANLEY.
This table shows 123 institutional shareholders of the security as of 30 Sep 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.